Development and characterization of xenograft model systems for adenoid cystic carcinoma

Laboratory Investigation

Volumn 91, Issue 10, 2011, Pages 1480-1490

  Moskaluk, Christopher A ^a   Baras, Alexander S ^a   Mancuso, Stefani A ^a   Fan, Hao ^a   Davidson, Robert J ^a   Dirks, Dawn C ^a   Golden, Wendy L ^a   Frierson, Henry F ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

adenoid cystic carcinoma; MYB; NFIB; oncogene fusion; xenograft

Indexed keywords

ADENOID CYSTIC CARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUSION; GENE LOCUS; GENE REARRANGEMENT; GENE TRANSLOCATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KARYOTYPING; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; ONCOGENE MYB; ONCOGENE NFIB; PRIORITY JOURNAL; RNA TRANSCRIPTION; TUMOR XENOGRAFT;

EID: 80053365712     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2011.105     Document Type: Article

References (24)

1. Ellis GL, Auclair PL. Tumors of the Salivary Glands, Vol. Fascicle 17, 3rd edn AFIP: Washington, DC, 1996.
2. Spiro RH, Huvos AG, Strong EW. Adenoid cystic carcinoma of salivary gland origin: a clinicopathologic study of 242 cases. Am J Surg 1974;128:512-520.
3. Isacsson G, Shear M. Intraoral salivary gland tumors: a retrospective study of 201 cases. J Oral Pathol 1983;12:57-62. (Pubitemid 13110098)
4. Eveson JW, Cawson RA. Salivary gland tumours. A review of 2410 cases with particular reference to histological types, site, age and sex distribution. J Pathol 1985;146:51-58. (Pubitemid 15041575)
5. Bonaparte JP, Hart R, Trites J, et al. Incidence of adenoid cystic carcinoma in Nova Scotia: 30-year population-based epidemiologic study. J Otolaryngol Head Neck Surg 2008;37:642-648.
6. Wiseman SM, Popat SR, Rigual NR, et al. Adenoid cystic carcinoma of the paranasal sinuses or nasal cavity: a 40-year review of 35 cases. Ear Nose Throat J 2002;81:510-514, 516-517.
7. Font RL, Smith SL, Bryan RG. Malignant epithelial tumors of the lacrimal gland: a clinicopathologic study of 21 cases. Arch Ophthalmol 1998;116:613-616. (Pubitemid 28414576)
8. Ghabach B, Anderson W, Curtis R, et al. Adenoid cystic carcinoma of the breast in the United States (1977 to 2006): a population-based cohort study. Breast Cancer Res 2010;12:R54.
9. Vander Poorten VL, Balm AJ, Hilgers FJ, et al. Prognostic factors for long term results of the treatment of patients with malignant submandibular gland tumors. Cancer 1999;85:2255-2264. (Pubitemid 29215567)
10. Fordice J, Kershaw C, el-Naggar A, et al. Adenoid cystic carcinoma of the head and neck. Predictors of morbidity and mortality. Arch Otolaryngol Head Neck Surg 1999;125:149-152. (Pubitemid 29085262)
11. Nordkvist A, Mark J, Gustavsson H, et al. Nonrandom chromosome rearrangements in adenoid cystic carcinoma of the salivary glands. Genes Chromosomes Cancer 1994;10:115-121. (Pubitemid 24155981)
12. Persson M, Andren Y, Mark J, et al. Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci USA 2009;106:18740-18744.
13. Phuchareon J, Ohta Y, Woo JM, et al. Genetic profiling reveals cross-contamination and misidentification of 6 adenoid cystic carcinoma cell lines: ACC2, ACC3, ACCM, ACCNS, ACCS and CAC2. PLoS ONE 2009;4:e6040.
14. Frierson Jr HF, El-Naggar AK, Welsh JB, et al. Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma. Am J Pathol 2002;161:1315-1323.
15. Rooney DE, Czepulkowski BH. Malignancy and Acquired Abnormalities Human Cytogenetics: A Practical Approach, Vol. II, 2nd edn. Oxford University Press: New York, 1992.
16. Shaffer L, Slovak M, Campbell L. An International System for Human Cytogenetics Nomenclature. S. Karger: Basel, 2009.
17. Edwards PC, Bhuiya T, Kelsch RD. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;97: 613-619. (Pubitemid 38638465)
18. Emanuel P, Wang B, Wu M, et al. p63 Immunohistochemistry in the distinction of adenoid cystic carcinoma from basaloid squamous cell carcinoma. Mod Pathol 2005;18:645-650. (Pubitemid 40676375)
19. Conley J, Dingman DL. Adenoid cystic carcinoma in the head and neck (cylindroma). Arch Otolaryngol 1974;100:81-90.
20. West RB, Kong C, Clarke N, et al. MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation. Am J Surg Pathol 2011;35:92-99.
21. Kelland LR. Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development. Eur J Cancer 2004;40:827-836. (Pubitemid 38519761)
22. Johnson JI, Decker S, Zaharevitz D, et al. Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials. Br J Cancer 2001;84:1424-1431. (Pubitemid 32522115)
23. Dong X, Guan J, English JC, et al. Patient-derived first generation xenografts of non-small cell lung cancers: promising tools for predicting drug responses for personalized chemotherapy. Clin Cancer Res 2010;16:1442-1451.
24. Fichtner I, Slisow W, Gill J, et al. Anticancer drug response and expression of molecular markers in early-passage xenotransplanted colon carcinomas. Eur J Cancer 2004;40:298-307. (Pubitemid 38077034)